Cannabinoids in MS: potentially useful but not just yet!
Thompson
Alan J
AJ
Baker
David
D
D000818:Animals; D002186:Cannabinoids / Q000009:adverse effects / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D004195:Disease Models, Animal; D004333:Drug Administration Routes; D006801:Humans; D009103:Multiple Sclerosis / Q000188:drug therapy*; D009128:Muscle Spasticity / Q000209:etiology; D009426:Netherlands; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome; D006113:United Kingdom
D002186:Cannabinoids